Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

RA and SLE Linked to Adverse Outcomes After Acute CV Events

Both rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) are consistently associated with adverse outcomes following acute cardiovascular (CV) events, a new study found. The population-based study identified adult patients who experienced first-time acute myocardial infarction (n = 191,008), intracranial hemorrhage (n = 169,923) and ischemic stroke (n = 486,890) over a 13-year period. Odds ratios of in-hospital mortality and hazard ratios of overall mortality and adverse outcomes during long-term follow-up in relation to RA and SLE were estimated. Among the findings:

  • In each cohort, 748, 410, and 1,419 patients had established RA; 256, 292, and 622 patients had SLE.
  • Among acute myocardial infarction patients, RA and SLE were associated with in-hospital morality and overall mortality.
  • RA and SLE increased the risk of major adverse cardiac events.
  • After intracranial hemorrhage, patients with RA and SLE had higher risks of in-hospital mortality and overall mortality.
  • After ischemic stroke, RA and SLE increased in-hospital mortality.

Citation:

Lai CH, et al. Outcomes of acute cardiovascular events in rheumatoid arthritis and systemic lupus erythematosus: a population-based study. [Published online ahead of print October 10, 2019]. Rheumatology. doi:10.1093/rheumatology/kez456.